Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
Weill Medical College of Cornell University
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
BioNTech SE
Astellas Pharma Inc
Janssen Research & Development, LLC
Arcus Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Dana-Farber Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
Vividion Therapeutics, Inc.
University of California, Irvine
M.D. Anderson Cancer Center
R-Pharm
BeOne Medicines
H. Lee Moffitt Cancer Center and Research Institute
Wake Forest University Health Sciences
HC Biopharma Inc.
Kyowa Kirin Co., Ltd.